|

ALV-100 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Alveus Therapeutics, Inc.1

Indications

  • Overweight or Obese, Type 2 Diabetes1
  • Overweight or Obese Adults1
  • Weight Loss1
  • Diabetes1

Miami, Florida1 trial

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Clinical Pharmacology of Miami

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.